These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 28344197

  • 1. Effects of Food on the Pharmacokinetics of Omega-3-Carboxylic Acids in Healthy Japanese Male Subjects: A Phase I, Randomized, Open-label, Three-period, Crossover Trial.
    Shimada H, Nilsson C, Noda Y, Kim H, Lundström T, Yajima T.
    J Atheroscler Thromb; 2017 Sep 01; 24(9):980-987. PubMed ID: 28344197
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of Single and Multiple Doses of Omega-3 Carboxylic Acids in Healthy Chinese Subjects: A Phase I, Open-Label Study.
    Jing S, Zhang Z, Chen X, Miao R, Nilsson C, Lin Y.
    Clin Pharmacol Drug Dev; 2020 Nov 01; 9(8):985-994. PubMed ID: 32567203
    [Abstract] [Full Text] [Related]

  • 3. Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study.
    Dunbar RL, Gaudet D, Davidson M, Rensfeldt M, Yang H, Nilsson C, Kvarnström M, Oscarsson J.
    Lipids Health Dis; 2020 May 30; 19(1):117. PubMed ID: 32473640
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers.
    Offman E, Davidson M, Abu-Rashid M, Chai P, Nilsson C.
    Eur J Drug Metab Pharmacokinet; 2017 Oct 30; 42(5):815-825. PubMed ID: 28116646
    [Abstract] [Full Text] [Related]

  • 6. A Single-dose, Comparative Bioavailability Study of a Formulation containing OM3 as Phospholipid and Free Fatty Acid to an Ethyl Ester Formulation in the Fasting and Fed States.
    Lapointe JF, Harvey L, Aziz S, Jordan H, Hegele RA, Lemieux P.
    Clin Ther; 2019 Mar 30; 41(3):426-444. PubMed ID: 30799231
    [Abstract] [Full Text] [Related]

  • 7. Effects of a Self-micro-emulsifying Delivery System Formulation Versus a Standard ω-3 Acid Ethyl Ester Product on the Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid: A Study in Healthy Men and Women in a Fasted State.
    Maki KC, Palacios OM, Buggia MA, Trivedi R, Dicklin MR, Maki CE.
    Clin Ther; 2018 Dec 30; 40(12):2065-2076. PubMed ID: 30454850
    [Abstract] [Full Text] [Related]

  • 8. A novel self-micro-emulsifying delivery system (SMEDS) formulation significantly improves the fasting absorption of EPA and DHA from a single dose of an omega-3 ethyl ester concentrate.
    Qin Y, Nyheim H, Haram EM, Moritz JM, Hustvedt SO.
    Lipids Health Dis; 2017 Oct 16; 16(1):204. PubMed ID: 29037249
    [Abstract] [Full Text] [Related]

  • 9. Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of an Omega-3-Carboxylic Acid Formulation in Healthy Male Japanese Subjects: A Phase 1 Single-Blind, Randomized, Placebo-Controlled Trial.
    Noda Y, Nilsson C, Shimada H, Kim H, Lundström T, Yajima T.
    Clin Pharmacol Drug Dev; 2018 Feb 16; 7(2):177-187. PubMed ID: 28597973
    [Abstract] [Full Text] [Related]

  • 10. Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers.
    Rusca A, Di Stefano AF, Doig MV, Scarsi C, Perucca E.
    Eur J Clin Pharmacol; 2009 May 16; 65(5):503-10. PubMed ID: 19148629
    [Abstract] [Full Text] [Related]

  • 11. Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3-acid ethyl esters with an Advanced Lipid TechnologiesTM (ALT®)-based formulation.
    Lopez-Toledano MA, Thorsteinsson T, Daak AA, Maki KC, Johns C, Rabinowicz AL, Sancilio FD.
    J Clin Lipidol; 2017 May 16; 11(2):394-405. PubMed ID: 28502496
    [Abstract] [Full Text] [Related]

  • 12. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova(®) compared to Lovaza(®) in a pharmacokinetic single-dose evaluation) study.
    Davidson MH, Johnson J, Rooney MW, Kyle ML, Kling DF.
    J Clin Lipidol; 2012 May 16; 6(6):573-84. PubMed ID: 23312053
    [Abstract] [Full Text] [Related]

  • 13. A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid TechnologiesTM (ALT®) Improves Docosahexaenoic Acid and Eicosapentaenoic Acid Bioavailability Compared with Lovaza®.
    Lopez-Toledano MA, Thorsteinsson T, Daak A, Maki KC, Johns C, Rabinowicz AL, Sancilio FD.
    Clin Ther; 2017 Mar 16; 39(3):581-591. PubMed ID: 28189364
    [Abstract] [Full Text] [Related]

  • 14. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols.
    Cook CM, Hallaråker H, Sæbø PC, Innis SM, Kelley KM, Sanoshy KD, Berger A, Maki KC.
    Prostaglandins Leukot Essent Fatty Acids; 2016 Aug 16; 111():17-24. PubMed ID: 27151222
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of OM3-PL/FFA Pharmacokinetics After Single and Multiple Oral Doses in Healthy Volunteers.
    Lapointe JF, Harvey L, Aziz S, Hegele RA, Lemieux P.
    Clin Ther; 2019 Dec 16; 41(12):2500-2516. PubMed ID: 31679821
    [Abstract] [Full Text] [Related]

  • 16. Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology of dietary supplements.
    Galli C, Maggi FM, Risé P, Sirtori CR.
    Br J Clin Pharmacol; 2012 Jul 16; 74(1):60-5. PubMed ID: 22242645
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial comparing omega-3 fatty acid plasma levels after ingestion of emulsified and non-emulsified cod liver oil formulations.
    Conus N, Burgher-Kennedy N, van den Berg F, Kaur Datta G.
    Curr Med Res Opin; 2019 Apr 16; 35(4):587-593. PubMed ID: 30106311
    [Abstract] [Full Text] [Related]

  • 18. Strategies to improve bioavailability of omega-3 fatty acids from ethyl ester concentrates.
    Maki KC, Dicklin MR.
    Curr Opin Clin Nutr Metab Care; 2019 Mar 16; 22(2):116-123. PubMed ID: 30550388
    [Abstract] [Full Text] [Related]

  • 19. Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia.
    Davidson MH, Phillips AK, Kling D, Maki KC.
    Expert Rev Cardiovasc Ther; 2014 Sep 16; 12(9):1045-54. PubMed ID: 25089906
    [Abstract] [Full Text] [Related]

  • 20. Use of manufactured foods enriched with fish oils as a means of increasing long-chain n-3 polyunsaturated fatty acid intake.
    Lovegrove JA, Brooks CN, Murphy MC, Gould BJ, Williams CM.
    Br J Nutr; 1997 Aug 16; 78(2):223-36. PubMed ID: 9301413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.